Alkanolamine derivatives and pharmaceutical compositions and use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424324, 424286, 424300, 260465D, A61K 31275, A61K 31165, C07C12150, C07C12160

Patent

active

041675819

ABSTRACT:
1-Aryloxy-3-aminoalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess .beta.-adrenergic blocking activity and some of them additionally possess cardiac stimulant activity. Representative of the compounds disclosed is 1-(2-cyanophenoxy)-3-.beta.(4-hydroxyphenylacetamido)ethylamino-2-propanol .

REFERENCES:
patent: 3459782 (1969-08-01), Koppe et al.
patent: 3663607 (1972-05-01), Barrett et al.
patent: 3712927 (1973-01-01), Howe et al.
patent: 3732277 (1973-05-01), Koppe et al.
patent: 3933911 (1976-01-01), Main
patent: 3961072 (1976-06-01), Cox et al.
patent: 4010189 (1977-03-01), Smith
patent: 4034106 (1977-07-01), Smith
patent: 4041075 (1977-08-01), Smith

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Alkanolamine derivatives and pharmaceutical compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkanolamine derivatives and pharmaceutical compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkanolamine derivatives and pharmaceutical compositions and use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-478162

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.